glp 1 and sglt2 Frontiers Combining glucagon-like peptide-1 receptor agonists

It's not just about whether they can help, but how they can be integrated into treatment plans

My hope is that by explaining, and potentially convincing you of, their inevitability and the health inequity that will arise from delaying coverage, the conversation shifts away from should these be covered? to how do we ensure everyone who needs them is covered as soon as possible? How do we, collectively, best fight for patient access to these new revolutionary treatments

During your consultation, your provider will review your health history and recommend the treatment that best meets your individual needs

If youve been using a compounded GLP-1, this means youll likely need to switch to a brand-name GLP-1